Luminex 合作伙伴

PPD Laboratories offers a full range of services across a wide variety of vaccines from legacy childhood diseases and seasonal flu to endemic pathogens and novel therapeutic vaccines. They are dedicated to helping you achieve the highest scientific standards for your programs and gain development efficiencies that speed the introduction of life-changing vaccines.

• Application Area: Vaccines
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

PerkinElmer’s screening solutions protect the health of pregnant women and newborn babies around the world, empowering earlier detection, enabling more effective treatment and saving lives.

• Application Area: Newborn Screening
• Target: Nucleic Acid, Protein
• Primary Business: Kits, Testing Services
• Market Availability: Global
• Regulatory Classification: IVD

One Lambda offers the largest portfolio of assays for low- to high-resolution detection. Their selection of reagents for the LABScreen™ line of products are powered by xMAP^® Technology. LABScreen assays produce trusted results, with consistency and high sensitivity, and are considered to be the gold standard in HLA antibody detection.

• Application Area: HLA
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

Oncimmune uses xMAP^® Technology to profile autoantibodies in clinical samples in order to characterise disease and predict immune-related adverse events (irAEs) and their response to therapy. The platform allows multiplexing of antigens, enabling thousands of autoantibodies to be profiled from a small sample of serum or plasma. Learn more about Oncimmune in this blog.

• Application Area: Oncology
• Target: Protein
• Primary Business: Testing Services
• Market Availability: Global
• Regulatory Classification: RUO

NMI TT Pharmaservices designs, establishs, and validates miniaturized, multiplexed immunoassays for a multitude of applications such as PK/PD studies, drug-induced organ injury, pathogen infections, and protein-protein interactions. Their DigiWest^® technology is very close to western blot, but through Luminex bead-based multiplexing, the system is able to analyze up to 800 total and phospho proteins per sample in one run.

• Application Area: Biomarker Screening, Vaccines
• Target: Protein
• Primary Business: Testing Services
• Market Availability: Europe
• Regulatory Classification: RUO

ColoPlex™ provides patients and physicians a simple, accurate blood testing option to detect colorectal cancer. This early detection blood test is aimed at driving the right people to confirmatory colonoscopy, reducing overall costs of screening programs and improving patient outcomes. Utilizing a novel machine learning algorithm coupled with Luminex’s leading multiplex platform to measure numerous proteins in a single patient blood sample, ColoPlex™ can provide more information to physicians so that they can diagnose disease early.

• Application Area: Oncology
• Target: Protein
• Primary Business: Kits
• Market Availability: Europe
• Regulatory Classification: IVD

AtomLife liquichip is a multi-detection product specially developed for biological assays based on xMAP^® Technology. By combining advanced fluidics, laser analysis, and high-speed digital signal processing technology with proprietary microsphere technology, xMAP Technology enables a high degree of multiplexing within a single sample volume.

• Target: Protein
• Primary Business: Kits, Testing Services
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

Mosaic Diagnostics provides allergy testing services for the United States.

• Application Area: Allergy
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

MilliporeSigma is a leader in biomarker immunoassays, including >200 MILLIPLEX^® multiplex kits with ~1,200 analytes across 11 species, all with best-in-class verification to ensure reproducible results you can trust. In addition, MilliporeSigma offers custom immunoassay development services and the full range of Luminex instrumentation for all your research needs.

• Application Area: Autoimmune, Biomarker Screening, Cardiovascular, Neurological, Oncology, Vaccines
• Target: Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: RUO

The recomBead CXCL13 is a quantitative in vitro test for the detection of CXCL13 in human CSF on the basis of Luminex multiplex technology. The test system displays a very high sensitivity and precision in conjunction with a wide linear range. Due to multiplex integration, any additional controls are reduced to a minimum.

• Application Area: Infectious Disease
• Target: Protein
• Primary Business: Kits
• Market Availability: Europe
• Regulatory Classification: IVD